Want to join the conversation?
U.S. drug delivery firm $CTLT said that 4Q16 revenue rose 4% as reported and rose 6% in constant currency to $532MM, all of which was organic, with all segments contributing to the growth. For full-year 2016, the company recorded revenue growth of 6% at a constant currency vs. 2015, despite the challenges related to Beinheim facility suspension.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?